Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

Zogenix, Inc. (ZGNX) 1.60 0.00
Price Open:1.62Day's Range:0.00000 - 2.94500
Price Close:1.6052wk Range:0.00000 - 3.30
Price Day Change:0.00Volume:309,228
Price % Change:0.00Market Cap:161.3M
Bid:1.56000PE Ratio:0
Ask:1.79000EPS Diluted:-0.65
Trade ZGNX NOW!

The Latest On ZGNX

US Stock Futures Slightly Lower Ahead Of CPI 3/15/13 6:09am
Earnings Scheduled For March 15, 2013 3/15/13 5:00am
UPDATE: Brinson Patrick Initiates Zogenix at Market Putperform on Zophydro Prospects 3/5/13 8:30am
Benzinga's Small Cap Movers for Wednesday February 27, 2013 2/27/13 7:28pm
Zogenix Unlikely to Receive Action Letter for NDA for Zohydro ER by PDUFA Goal Date of March 1, 2013 2/26/13 9:34pm
Zogenix Sees Q4 Sales of $13.4M, Unit Volume Up 9% QoQ; Cited Effect from Hurricane Sandy 1/7/13 8:39am
Zogenix Announces Positive Relday Phase 1 Clinical Trial Results 1/3/13 8:40am
Zogenix Shares Rally as FDA Redschedules Hydrocodone Drugs Panel 12/18/12 5:03pm
UPDATE: Stifel Nicolaus Downgrades Zogenix to Hold Following FDA Panel 12/10/12 12:07pm
UPDATE: Oppenheimer Downgrades Zogenix to Perform Following Negative Panel 12/10/12 11:21am
Morning Market Losers 12/10/12 11:02am
Zogenix to Host Conference Call Following FDA Panel Meeting, Will Be at 6:30PM 12/7/12 8:40am
more
Press Releases
Zogenix Reports First Quarter 2013 Financial Results 5/9/13 GlobeNewswire
Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results 5/3/13 GlobeNewswire
Zogenix Reports Positive Top-Line Results From Extended Relday(TM) Phase 1 Clinical Trial 5/2/13 GlobeNewswire
Zogenix and Battelle Extend DosePro Co-Marketing Partnership 3/27/13 GlobeNewswire
Zogenix Reports Fourth Quarter and Full Year 2012 Financial Results 3/15/13 GlobeNewswire
Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2012 Financial Results 3/7/13 GlobeNewswire
Zogenix Provides Update on Zohydro(TM) ER Regulatory Review 2/26/13 GlobeNewswire
Zogenix Announces Preliminary Fourth Quarter 2012 Gross Product Sales 1/7/13 GlobeNewswire
DURECT Announces Positive Results from Relday™ Phase 1 Clinical Trial 1/3/13 Newswire
Zogenix Reports Positive Results From Relday(TM) Phase 1 Clinical Trial 1/3/13 GlobeNewswire
Trading of Zogenix Common Stock Halted 12/7/12 GlobeNewswire
Zogenix Appoints New Chief Commercial Officer 11/26/12 GlobeNewswire

Get the latest ZGNX stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Zogenix, Inc. stock price.

Partner Headlines
Loss Narrows at Zogenix - Analyst Blog 3/18/13
Weekly CFO Buys Highlight: NGL, UNTK, ZGNX, VTSS, RVSB 12/24/12
Zogenix Shares Plunge 52% on FDA Panel's Turn-Down of Painkiller 12/10/12
An Extended Release Could Mean Big Business for Zogenix 10/4/12
How Close Are These Biotechs to Breakouts? DARA, ZGNX, ANTH in Focus. 9/17/12
Mixed 3Q for Covidien, Profit Drops - Analyst Blog 7/26/12
Earnings Preview: Covidien - Analyst Blog 7/23/12
Conmed Healthcare Management, Zogenix Among Stocks Gapping Up Monday 7/16/12
Covidien Promotes Zogenix's Product - Analyst Blog 6/8/12
Health Care Sector Wrap 5/30/12
Now What for Migraine Plays? MAP Pharmaceuticals (MAPP), Impax Laboratories (IPXL), NuPathe (PATH), Zogenix (ZGNX) 3/28/12
Company News for March 12, 2012 - Corporate Summary 3/12/12